GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.15G009700	P00149		1	4.80276196975134e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P00419	2-Iminobutanoate	1	1.96473521392269e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P04948		1	3.66131148607855e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P05141	2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione	1	6.92237300562078e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P06259		1	6.73003324004209e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P07533	Carpachromene dimethyl ether	1	1.86523783693151e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P08794	(-)-Acaterin	1	7.61421811015416e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P08991	Triadimefon	1	7.2602949324888e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P09640	2-(Trifluoromethoxy)anisole	1	4.19444509305344e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P11088	8-trans-[2-(6-Benzoyloxy-4-hydroxy-2-methoxy-3-methylphenyl)ethenyl]-5-methoxyflavan-7-ol	1	2.76187690597536e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P11109	gamma-Secretase Inhibitor XXI	1	2.17283548476369e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P11387	4-({(1R)-1-[(R)-hydroxy(phenoxy)phosphoryl]pentyl}amino)-4-oxobutanoic acid	1	7.22524664951783e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P12932	Desulfoglucotropeolin	1	2.63369518980193e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P13777	Lidamidine	1	2.2950197620685e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P14011	(+)-cis-5,6-Dihydro-5-hydroxy-4-methoxy-6-(2-phenylethyl)-2H-pyran-2-one	1	7.41856014313276e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P14784	5,7-octadienoic acid	1	7.90819080727956e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P16389	Ethyl 2-amino-3-sulfanylpropanoate	1	4.19694773907158e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P17566	Antibiotic KA 7367B	1	6.72609574578165e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P19126	BL IV	1	7.70218336109771e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P21264		1	9.86346768129808e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P22455	Nocloprost	1	5.66132390493786e-14	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P25253	Lolitriol	1	1.90965365856896e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P25779	allo-Aromadendrane-10beta,14-diol	1	9.67084097532511e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P25880	1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphoserine	1	4.65633957579355e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P27987	(S)-2,3-Dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid 5-[glucosyl-(1->4)-b-D-glucoside]	1	9.52837549469555e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P28138	1-(1-Methoxy-1-methylethyl)-4-methylbenzene	1	7.39144211406069e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P30039	Tigloylseneganolide A	1	6.24002128867518e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P31735	Thuja-2,4[10]-diene	1	5.02229426428608e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P31742	alpha-Curcumene	1	9.41445626405878e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P31840	CCR3 Antagonist	1	3.84620464305792e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P31843	Koraiol	1	8.89093810551406e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P32474	Thymol glucoside	1	3.4370904622371e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P33516		1	4.44060129784458e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P33647	Antibiotic FA 1180B	1	6.54019475905185e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P33665	Validamycin A	1	4.47719327341107e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P34983	(8S,9R,11S,13S,14S,17S)-13-Methyl-11-[4-[5-(4,4,5,5,5-pentafluoropentylsulfonyl)pentoxy]phenyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol	1	9.75620117238197e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P35079	(1E)-1-{[(Diaminomethylidene)amino]imino}-2,3-dihydro-1H-indene-4-carboximidamide	1	1.68788384135832e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P35509		1	8.06810875887249e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P36255	(E)-4-Oxo-2-nonenoic acid	1	5.03623581815818e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P37876	CDP-DG(PGJ2/i-20:0)	1	5.79888186501721e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P39724	Akt inhibitor VIII	1	3.01095425457691e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P45710	1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'D-myo-inositol-3'-phosphate)	1	2.81457770330698e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P47213		1	1.06722821830161e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.15G009700	P51993	Gadoteridol	1	2.3240578526418e-11	overlap	1e-10	<	Wm82.a2.v1